Global Metastatic Melanoma Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Metastatic Melanoma Drug

• 1.1 Definition of Metastatic Melanoma Drug
• 1.2 Metastatic Melanoma Drug Segment by Type
  • 1.2.1 Global Metastatic Melanoma Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AGI-134
  • 1.2.3 ALT-801
  • 1.2.4 ALT-803
  • 1.2.5 AMG-232
  • 1.2.6 Others
• 1.3 Metastatic Melanoma Drug Segment by Applications
  • 1.3.1 Global Metastatic Melanoma Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Metastatic Melanoma Drug Overall Market
  • 1.4.1 Global Metastatic Melanoma Drug Revenue (2014-2025)
  • 1.4.2 Global Metastatic Melanoma Drug Production (2014-2025)
  • 1.4.3 North America Metastatic Melanoma Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Metastatic Melanoma Drug Status and Prospect (2014-2025)
  • 1.4.5 China Metastatic Melanoma Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Metastatic Melanoma Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Metastatic Melanoma Drug Status and Prospect (2014-2025)
  • 1.4.8 India Metastatic Melanoma Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Metastatic Melanoma Drug
• 2.3 Manufacturing Process Analysis of Metastatic Melanoma Drug
• 2.4 Industry Chain Structure of Metastatic Melanoma Drug

3 Development and Manufacturing Plants Analysis of Metastatic Melanoma Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Metastatic Melanoma Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Metastatic Melanoma Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Metastatic Melanoma Drug Production and Capacity Analysis
• 4.2 Metastatic Melanoma Drug Revenue Analysis
• 4.3 Metastatic Melanoma Drug Price Analysis
• 4.4 Market Concentration Degree

5 Metastatic Melanoma Drug Regional Market Analysis

• 5.1 Metastatic Melanoma Drug Production by Regions
  • 5.1.1 Global Metastatic Melanoma Drug Production by Regions
  • 5.1.2 Global Metastatic Melanoma Drug Revenue by Regions
• 5.2 Metastatic Melanoma Drug Consumption by Regions
• 5.3 North America Metastatic Melanoma Drug Market Analysis
  • 5.3.1 North America Metastatic Melanoma Drug Production
  • 5.3.2 North America Metastatic Melanoma Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Metastatic Melanoma Drug Import and Export
• 5.4 Europe Metastatic Melanoma Drug Market Analysis
  • 5.4.1 Europe Metastatic Melanoma Drug Production
  • 5.4.2 Europe Metastatic Melanoma Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Metastatic Melanoma Drug Import and Export
• 5.5 China Metastatic Melanoma Drug Market Analysis
  • 5.5.1 China Metastatic Melanoma Drug Production
  • 5.5.2 China Metastatic Melanoma Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Metastatic Melanoma Drug Import and Export
• 5.6 Japan Metastatic Melanoma Drug Market Analysis
  • 5.6.1 Japan Metastatic Melanoma Drug Production
  • 5.6.2 Japan Metastatic Melanoma Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Metastatic Melanoma Drug Import and Export
• 5.7 Southeast Asia Metastatic Melanoma Drug Market Analysis
  • 5.7.1 Southeast Asia Metastatic Melanoma Drug Production
  • 5.7.2 Southeast Asia Metastatic Melanoma Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Metastatic Melanoma Drug Import and Export
• 5.8 India Metastatic Melanoma Drug Market Analysis
  • 5.8.1 India Metastatic Melanoma Drug Production
  • 5.8.2 India Metastatic Melanoma Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Metastatic Melanoma Drug Import and Export

6 Metastatic Melanoma Drug Segment Market Analysis (by Type)

• 6.1 Global Metastatic Melanoma Drug Production by Type
• 6.2 Global Metastatic Melanoma Drug Revenue by Type
• 6.3 Metastatic Melanoma Drug Price by Type

7 Metastatic Melanoma Drug Segment Market Analysis (by Application)

• 7.1 Global Metastatic Melanoma Drug Consumption by Application
• 7.2 Global Metastatic Melanoma Drug Consumption Market Share by Application (2014-2019)

8 Metastatic Melanoma Drug Major Manufacturers Analysis

• 8.1 Merck & Co., Inc.
  • 8.1.1 Merck & Co., Inc. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.1.2 Merck & Co., Inc. Product Introduction, Application and Specification
  • 8.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Merck KGaA
  • 8.2.1 Merck KGaA Metastatic Melanoma Drug Production Sites and Area Served
  • 8.2.2 Merck KGaA Product Introduction, Application and Specification
  • 8.2.3 Merck KGaA Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Millennium Pharmaceuticals, Inc.
  • 8.3.1 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.3.2 Millennium Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Morphotek, Inc.
  • 8.4.1 Morphotek, Inc. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.4.2 Morphotek, Inc. Product Introduction, Application and Specification
  • 8.4.3 Morphotek, Inc. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 NewLink Genetics Corporation
  • 8.5.1 NewLink Genetics Corporation Metastatic Melanoma Drug Production Sites and Area Served
  • 8.5.2 NewLink Genetics Corporation Product Introduction, Application and Specification
  • 8.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Novartis AG
  • 8.6.1 Novartis AG Metastatic Melanoma Drug Production Sites and Area Served
  • 8.6.2 Novartis AG Product Introduction, Application and Specification
  • 8.6.3 Novartis AG Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Omeros Corporation
  • 8.7.1 Omeros Corporation Metastatic Melanoma Drug Production Sites and Area Served
  • 8.7.2 Omeros Corporation Product Introduction, Application and Specification
  • 8.7.3 Omeros Corporation Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Oncolytics Biotech Inc.
  • 8.8.1 Oncolytics Biotech Inc. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.8.2 Oncolytics Biotech Inc. Product Introduction, Application and Specification
  • 8.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 OncoSec Medical Inc.
  • 8.9.1 OncoSec Medical Inc. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.9.2 OncoSec Medical Inc. Product Introduction, Application and Specification
  • 8.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Ono Pharmaceutical Co., Ltd.
  • 8.10.1 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Production Sites and Area Served
  • 8.10.2 Ono Pharmaceutical Co., Ltd. Product Introduction, Application and Specification
  • 8.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer Inc.
• 8.12 Pharmis Biofarmaceutica, Lda.
• 8.13 Philogen S.p.A.
• 8.14 Plexxikon Inc.

9 Development Trend of Analysis of Metastatic Melanoma Drug Market

• 9.1 Global Metastatic Melanoma Drug Market Trend Analysis
  • 9.1.1 Global Metastatic Melanoma Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Metastatic Melanoma Drug Regional Market Trend
  • 9.2.1 North America Metastatic Melanoma Drug Forecast 2019-2025
  • 9.2.2 Europe Metastatic Melanoma Drug Forecast 2019-2025
  • 9.2.3 China Metastatic Melanoma Drug Forecast 2019-2025
  • 9.2.4 Japan Metastatic Melanoma Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Metastatic Melanoma Drug Forecast 2019-2025
  • 9.2.6 India Metastatic Melanoma Drug Forecast 2019-2025
• 9.3 Metastatic Melanoma Drug Market Trend (Product Type)
• 9.4 Metastatic Melanoma Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Metastatic Melanoma Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List